The Safety of Direct-Acting Antiviral Treatment for Hepatitis C Virus in Egyptian Patients With Ischemic Heart Disease and Mildly Impaired Systolic Function

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Abouomar Mahmoud A.; Yousef Mohamed; Elsheikh Ayman

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN HEART JOURNAL Year:2021 | Volume:22 | Issue:3 Page(s): 13-22

Download Full-Text

View:

117

Download:

Cites:

Information Journal Paper

Title

The Safety of Direct-Acting Antiviral Treatment for Hepatitis C Virus in Egyptian Patients With Ischemic Heart Disease and Mildly Impaired Systolic Function

Author(s)

Abouomar Mahmoud A. | Yousef Mohamed | Elsheikh Ayman | Issue Writer Certificate

Keywords

Hepatitis C virus

Ischemic heart disease

Direct-acting antiviral

ECG

Echocardiography

Abstract

Background: Hepatitis C virus (HCV) infection is considered a public health problem in Egypt. The use of direct-acting antivirals (DAAs) in patients infected with HCV has been shown to be effective. The cardiac safety of these antivirals remains uncertain, however. This study aimed to assess the safety of the use of DAAs in patients suffering from ischemic heart disease (IHD) with mildly impaired systolic function. Method: This prospective cohort study was performed on 200 patients with chronic HCV infection scheduled for DAA use. The patients were divided into 2 groups: Group I comprised 96 patients with IHD and mildly impaired systolic function and Group II comprised 104 patients without IHD and with normal left ventricular ejection fractions. Both groups received sofosbuvir (400 mg) and daclatasvir (60 mg) daily for 12 weeks. Electrocardiography and echocardiography were performed prior to the start, during, and after 12 weeks of treatment. Result: At the end of the treatment period, no changes were observed in the patients’ cardiac symptoms and signs. No significant changes were also detected in electrocardiographic parameters, including the QTc interval in Group I (P =0. 60) or Group II (P =0. 63). Moreover, no changes were recorded in both groups regarding left ventricular systolic and diastolic functions (ie, the dimension, the ejection fraction, the transmitral E/A ratio, the E/E’ ratio, and the deceleration time), the tricuspid annular plane systolic excursion, right ventricular systolic pressure, and the mean pulmonary artery pressure. Conclusions: The use of DAAs to treat Egyptian patients infected with HCV was safe in those suffering from IHD with mildly impaired systolic function. The treatment with DAAs exerted no effects on the QTc interval and the function of the left and right ventricles.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

Abouomar, Mahmoud A., Yousef, Mohamed, & Elsheikh, Ayman. (2021). The Safety of Direct-Acting Antiviral Treatment for Hepatitis C Virus in Egyptian Patients With Ischemic Heart Disease and Mildly Impaired Systolic Function. IRANIAN HEART JOURNAL (IHJ), 22(3), 13-22. SID. https://sid.ir/paper/690954/en

Vancouver: Copy

Abouomar Mahmoud A., Yousef Mohamed, Elsheikh Ayman. The Safety of Direct-Acting Antiviral Treatment for Hepatitis C Virus in Egyptian Patients With Ischemic Heart Disease and Mildly Impaired Systolic Function. IRANIAN HEART JOURNAL (IHJ)[Internet]. 2021;22(3):13-22. Available from: https://sid.ir/paper/690954/en

IEEE: Copy

Mahmoud A. Abouomar, Mohamed Yousef, and Ayman Elsheikh, “The Safety of Direct-Acting Antiviral Treatment for Hepatitis C Virus in Egyptian Patients With Ischemic Heart Disease and Mildly Impaired Systolic Function,” IRANIAN HEART JOURNAL (IHJ), vol. 22, no. 3, pp. 13–22, 2021, [Online]. Available: https://sid.ir/paper/690954/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops